16 May 2020 the Russian Government enacted the rules on online sales and delivery of medicines (the Rules). According to the Rules, online sales of medicines are allowed. The exceptions are: RX medicines, narcotic and psychotropic medicines, and medicines containing more than 25% ethyl alcohol.

The State Duma of the Russian Federation adopted the Law¹ in the third reading which provides the opportunity to require early termination of leases for tenants affected by the deteriorating economic situation resulting from the spread of a new coronavirus infection. The final version of the Law in this part has undergone multiple fundamental changes.

This refers to the fast track registration and conduct of clinical trials, which is valid until January 1, 2021 and is worked out for medical drugs potentially effective in the fight against COVID-19.

Partner, Head of the bankruptcy and restructuring practice of Lidings Stepan Guzey will speak at the Online Litigation Forum organized by Pravo.ru.

May 27th 2020 Julia Kuzmenko, Associate in Lidings’ Corporate and M&A practice, will take part in ONLINE PHARMA ADVANCE CONFERENCE organized by Business Summit of Future.

Partner, Head of the Intellectual Property practice of Lidings Boris Malakhov will take part in an online event PRAVO TECH On air.

Partner, Head of the bankruptcy and restructuring practice of Lidings Stepan Guzey will speak at a practical webinar dedicated to the Insolvency Moratorium organized by Sobytie event agency.

The new review of the most notable antitrust disputes in Life Sciences in Russia and CIS.

• pdf, 946.35 kb

On April 30, 2020, The Presidium of the Supreme Court of the Russian Federation (hereinafter referred to as “the SC”) adopted the Review on certain matters of judicial practice related to the application of legislation and measures to combat the spread of the novel coronavirus infection (COVID-19) No. 2 (hereinafter “Review”). The release of the second review was known in advance: it was reported on the official website of the SC, and after the release of the first review many unresolved issues remained.